Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Comments on the ESHRE recommendations for the treatment of minimal endometriosis in infertile women..
Reprod Biomed Online. 36(1), 84-87.
(2018). Comments on gestational diabetes mellitus: from pathophysiology to clinical practice..
Hormones (Athens). 14(3), 335-44.
(2015). Commentary/guest editorial on: "Treatment of fragmented and severely encrusted urethral D-J stent forgotten for 11 years through multimodal endourological methods"..
Urol Ann. 11(1), 113-114.
(2019). Commentary: popliteal approach in the supine position after failed antegrade angioplasty for chronic superficial femoral artery occlusion..
J Endovasc Ther. 17(2), 259-60.
(2010). Commentary on "Prophylaxis against HBV recurrence after liver transplantation for HBV-related endstage liver diseases with severe hypersplenism and splenomegaly: Role of splenectomy"..
J Surg Res. 183(2), 548-9.
(2013). Commentary on "Preemptive therapy with steroids but not macrolides improves gas exchange in caustic-injured donor lungs"..
J Surg Res. 171(2), e175-7.
(2011). Commentary on "Optimizing chimerism level through bone marrow transplantation and irradiation to induce long-term tolerance to composite tissue allotransplantation"..
J Surg Res. 185(1), e59-60.
(2013). Commentary on "Liver transplantation with donation-after-cardiac-death donors: a comprehensive update"..
J Surg Res. 184(2), 794-5.
(2013). Commentary on: Lipid peroxidation in machine perfusion of older donor kidneys..
J Surg Res. 185(1), e43-4.
(2013). Commentary on "Interaction between Kupffer cells and platelets in the early period of hepatic ischemia-reperfusion injury"..
J Surg Res. 179(1), e51-2.
(2013). Commentary on: Comparing the efficacy of disease-modifying therapies in multiple sclerosis..
Mult Scler Relat Disord. 21, 117-119.
(2018). Commentary on "Combined treatment with regulatory T cells and vascularized bone marrow transplantation creates mixed chimerism and donor-specific tolerance to vascularized composite allografts without cytoreductive conditioning"..
J Surg Res. 185(1), e37-8.
(2013). Commentary on: Age-related differences in hepatic ischemia/reperfusion: gene activation, liver injury, and protective effect of melatonin..
J Surg Res. 185(1), e51-2.
(2013). Commentary: Nonalcoholic or metabolic dysfunction-associated fatty liver disease? The epidemic of the 21st century in search of the most appropriate name..
Metabolism. 113, 154413.
(2020). Commentary: are blood and saliva sources of COVID-19 spread?.
Eur Rev Med Pharmacol Sci. 25(15), 4872-4874.
(2021). Commentary..
J Neurosci Rural Pract. 4(4), 397-8.
(2013). Comment to "atorvastatin improves disease activity of nonalcoholic steatohepatitis partly through its tumour necrosis factor-α-lowering property"..
Dig Liver Dis. 45(1), 82-3.
(2013). Comment on "Therapeutic Application of an Extract of Ameliorates the Development of Allergic Airway Disease"..
J Immunol. 200(9), 3027.
(2018). Comment on the systematic review and meta-analysis titled "Gestational diabetes and the risk of cardiovascular disease in women"..
Hormones (Athens). 19(3), 447-448.
(2020). Comment on "the influence of wall stress on AAA growth and biomarkers"..
Eur J Vasc Endovasc Surg. 39(6), 796; author reply 797.
(2010). Comment on "The correlation of Helicobacter pylori with the development of cholelithiasis and cholecystitis: the results of a prospective clinical study in Saudi Arabia"..
Eur Rev Med Pharmacol Sci. 20(1), 3-4.
(2016). Comment on: The Carbapenemase Menace: Do Dual Mechanisms Code for More Resistance?.
Infect Control Hosp Epidemiol. 37(11), 1392-1394.
(2016). Comment on: T2Candida MR as a predictor of outcome in patients with suspected invasive candidiasis starting empirical antifungal treatment: a prospective pilot study..
J Antimicrob Chemother. 74(2), 532-533.
(2019).
(2010).
(2019).